An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1262-8 ◽

2010 ◽

Vol 66 (6) ◽

pp. 1065-1070 ◽

Author(s):

Seiji Naito ◽

Taiji Tsukamoto ◽

Michiyuki Usami ◽

Hiroyuki Fujimoto ◽

Hideyuki Akaza

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Early Phase ◽

Phase Ii Trial ◽

Japanese Patients

Download Full-text

7147 Efficacy and safety of long-term use of sorafenib: final report of a phase II trial of sorafenib in Japanese patients with unresectable/metastatic renal cell carcinoma

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71480-6 ◽

2009 ◽

Vol 7 (2) ◽

pp. 437-438 ◽

Author(s):

H. Akaza ◽

S. Naito ◽

T. Tsukamoto ◽

M. Murai ◽

K. Fukino

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Trial ◽

Japanese Patients ◽

Final Report ◽

Efficacy And Safety

Download Full-text

Phase II Trial of Low Dose γ -Interferon in Metastatic Renal Cell Carcinoma

The Journal of Urology ◽

10.1016/s0022-5347(17)32587-9 ◽

1994 ◽

Vol 152 (3) ◽

pp. 841-845 ◽

Author(s):

Julie A. Ellerhorst ◽

Robert G. Kilbourn ◽

Robert J. Amato ◽

Alexander A. Zukiwski ◽

Elaine Jones ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Low Dose ◽

Phase Ii Trial ◽

Download Full-text

A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01

Clinical & Translational Oncology ◽

10.1007/s12094-010-0544-2 ◽

2010 ◽

Vol 12 (7) ◽

pp. 503-508 ◽

Author(s):

Joaquim Bellmunt ◽

Pablo Maroto-Rey ◽

José M. Trigo ◽

Joan Carles ◽

Vicente Guillem ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Trial ◽

Download Full-text

Granulocyte-Macrophage-Colony Stimulating Factor in Metastatic Renal Cell Carcinoma. A Phase II Trial

The Journal of Urology ◽

10.1016/s0022-5347(01)62035-4 ◽

1999 ◽

Vol 161 (2) ◽

pp. 733-733

Author(s):

B.I. Rini ◽

W.M. Stadler ◽

R.T. Spielberger ◽

M.J. Ratain ◽

N.J. Vogelzang

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Trial ◽

Colony Stimulating Factor ◽

Macrophage Colony Stimulating Factor ◽

Macrophage Colony ◽

Stimulating Factor

Download Full-text

Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma

Urology ◽

10.1016/j.urology.2008.05.032 ◽

2008 ◽

Vol 72 (4) ◽

pp. 898-902 ◽

Author(s):

Shanthi Marur ◽

James Eliason ◽

Lance K. Heilbrun ◽

Brenda Dickow ◽

Daryn W. Smith ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Trial ◽

Weekly Docetaxel

Download Full-text

Phase II Trial with High-Dose Elliptinium Acetate in Metastatic Renal Cell Carcinoma

Oncology ◽

10.1159/000226643 ◽

1988 ◽

Vol 45 (5) ◽

pp. 371-372 ◽

Author(s):

G. Piot ◽

J.P. Droz ◽

C. Theodore ◽

M. Ghosn ◽

J. Rouëssé ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Trial ◽

Download Full-text

A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma

Cancer ◽

10.1002/cncr.21410 ◽

2005 ◽

Vol 104 (9) ◽

pp. 1894-1900 ◽

Author(s):

Justin Lee ◽

David Hodgson ◽

Edward Chow ◽

Andrea Bezjak ◽

Pamela Catton ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Trial ◽

Palliative Radiotherapy

Download Full-text

Results of the phase II TRAXAR study: A randomized phase II trial of axitinib and TRC105 (TRAX) versus axitinib (AX) alone in patients with advanced or metastatic renal cell carcinoma (mRCC)

Annals of Oncology ◽

10.1093/annonc/mdz249.011 ◽

2019 ◽

Vol 30 ◽

pp. v362-v363 ◽

Author(s):

T.K. Choueiri ◽

J. Kocsis ◽

R.K. Pachynski ◽

A. Poprach ◽

M. Deshazo ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Trial ◽

Randomized Phase Ii

Download Full-text

Can the combination of temsirolimus and bevacizumab improve the treatment of metastatic renal cell carcinoma (mRCC)? Results of the randomized TORAVA phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.4516 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 4516-4516 ◽

Author(s):

B. J. Escudier ◽

S. Negrier ◽

G. Gravis ◽

C. Chevreau ◽

R. Delva ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Download Full-text

Axitinib second-line therapy for metastatic renal cell carcinoma (mRCC): Five-year (yr) overall survival (OS) data from a phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.4547 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 4547-4547 ◽

Author(s):

R. J. Motzer ◽

T. de La Motte Rouge ◽

A. L. Harzstark ◽

M. D. Michaelson ◽

G. Liu ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Overall Survival ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Trial ◽

Second Line ◽

Second Line Therapy ◽

Download Full-text